(Post-pandemic Era)-Global Advanced Parenteral Drug Delivery Devices Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
- Report Code : XYZ2438115
- Published On: Apr, 2021
- Category : Medical Devices
- Pages : 112
-
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. Research published a report for global Advanced Parenteral Drug Delivery Devices market in this environment.
In terms of revenue, this research report indicated that the global Advanced Parenteral Drug Delivery Devices market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Advanced Parenteral Drug Delivery Devices industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The Abbott Laboratories aims at producing XX K Units Advanced Parenteral Drug Delivery Devices in 2020, with XX % production to take place in global market, Amgen accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Advanced Parenteral Drug Delivery Devices Market Include by
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Advanced Parenteral Drug Delivery Devices Market
Abbott Laboratories
Amgen
Pfizer
Hoffmann-La Roche
AstraZeneca
Baxter
Dickinson
Boston Scientific
Bristol-Myers Squibb
GlaxoSmithKline
Novartis
Becton
AptarGroup
Major Type of Advanced Parenteral Drug Delivery Devices Covered in Research report:
Prefillable Syringes
Injectors Cartridges
Hypodermic Syringes
IV Catheters
Other Parenteral Delivery Devices
Application Segments Covered in Research Market
Central Nervous System Agents
Respiratory Agents
Hormones & Related Agents
Gastrointestinal Agents
Cardiovascular Agents
Anti-Infective Agents
Nutritional Agents
Genito-Urinary Agents
For any other requirements, please feel free to contact us and we will provide you customized report.
-
With tables and figures helping analyze worldwide (Post pandemic Era) Global Advanced Parenteral Drug Delivery Devices market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Global Advanced Parenteral Drug Delivery Devices Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope1.1 Product Details and Introduction
1.1.1 Prefillable Syringes -Product Introduction and Major Manufacturers
1.1.2 Injectors Cartridges -Product Introduction and Major Manufacturers
1.1.3 Hypodermic Syringes -Product Introduction and Major Manufacturers
1.1.4 IV Catheters -Product Introduction and Major Manufacturers
1.1.5 Other Parenteral Delivery Devices -Product Introduction and Major Manufacturers1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Advanced Parenteral Drug Delivery Devices Market Assessment, by Segmentation2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027)
2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027)
3 Regional Market Analysis3.1 China Advanced Parenteral Drug Delivery Devices Market
3.1.1 Top Companies leading Advanced Parenteral Drug Delivery Devices Development in China (2016-2021)
3.1.2 Sales Value of Major Company in China Market (2016-2021)
3.1.3 China Advanced Parenteral Drug Delivery Devices Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2026-2027)3.2 EU Advanced Parenteral Drug Delivery Devices Market
3.2.1 Top Companies leading Advanced Parenteral Drug Delivery Devices Development in EU (2016-2021)
3.2.2 Sales Value of Major Company in EU Market (2016-2021)
3.2.3 EU Advanced Parenteral Drug Delivery Devices Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2026-2027)3.3 USA Advanced Parenteral Drug Delivery Devices Market
3.3.1 Top Companies leading Advanced Parenteral Drug Delivery Devices Development in USA (2016-2021)
3.3.2 Sales Value of Major Company in USA Market (2016-2021)
3.3.3 USA Advanced Parenteral Drug Delivery Devices Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2026-2027)3.4 Japan Advanced Parenteral Drug Delivery Devices Market
3.4.1 Top Companies leading Advanced Parenteral Drug Delivery Devices Development in Japan (2016-2021)
3.4.2 Sales Value of Major Company in Japan Market (2016-2021)
3.4.3 Japan Advanced Parenteral Drug Delivery Devices Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2026-2027)3.5 India Advanced Parenteral Drug Delivery Devices Market
3.5.1 Top Companies leading Advanced Parenteral Drug Delivery Devices Development in India (2016-2021)
3.5.2 Sales Value of Major Company in India Market (2016-2021)
3.5.3 India Advanced Parenteral Drug Delivery Devices Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2026-2027)3.6 Southeast Asia Advanced Parenteral Drug Delivery Devices Market
3.6.1 Top Companies leading Advanced Parenteral Drug Delivery Devices Development in Southeast Asia (2016-2021)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021)
3.6.3 Southeast Asia Advanced Parenteral Drug Delivery Devices Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2026-2027)
3.7 South America Advanced Parenteral Drug Delivery Devices Market
3.7.1 Top Companies leading Advanced Parenteral Drug Delivery Devices Development in South America (2016-2021)
3.7.2 Sales Value of Major Company in South America Market (2016-2021)
3.7.3 South America Advanced Parenteral Drug Delivery Devices Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2026-2027)
4 Value Chain (Impact of COVID-19)4.1 Advanced Parenteral Drug Delivery Devices Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream4.2 COVID-19 Impact on Advanced Parenteral Drug Delivery Devices Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2027)5.1 Global Advanced Parenteral Drug Delivery Devices Sales and Growth Rate (2021-2027)
5.2 Global Advanced Parenteral Drug Delivery Devices Sales Value and Growth Rate (2021-2027)
6 Advanced Parenteral Drug Delivery Devices Competitive Analysis6.1 Abbott Laboratories
6.1.1 Abbott Laboratories Company Profiles
6.1.2 Abbott Laboratories Product Introduction
6.1.3 Abbott Laboratories Advanced Parenteral Drug Delivery Devices Production, Revenue (2016-2021)
6.1.4 SWOT Analysis6.2 Amgen
6.2.1 Amgen Company Profiles
6.2.2 Amgen Product Introduction
6.2.3 Amgen Advanced Parenteral Drug Delivery Devices Production, Revenue (2016-2021)
6.2.4 SWOT Analysis6.3 Pfizer
6.3.1 Pfizer Company Profiles
6.3.2 Pfizer Product Introduction
6.3.3 Pfizer Advanced Parenteral Drug Delivery Devices Production, Revenue (2016-2021)
6.3.4 SWOT Analysis6.4 Hoffmann-La Roche
6.4.1 Hoffmann-La Roche Company Profiles
6.4.2 Hoffmann-La Roche Product Introduction
6.4.3 Hoffmann-La Roche Advanced Parenteral Drug Delivery Devices Production, Revenue (2016-2021)
6.4.4 SWOT Analysis6.5 AstraZeneca
6.5.1 AstraZeneca Company Profiles
6.5.2 AstraZeneca Product Introduction
6.5.3 AstraZeneca Advanced Parenteral Drug Delivery Devices Production, Revenue (2016-2021)
6.5.4 SWOT Analysis6.6 Baxter
6.6.1 Baxter Company Profiles
6.6.2 Baxter Product Introduction
6.6.3 Baxter Advanced Parenteral Drug Delivery Devices Production, Revenue (2016-2021)
6.6.4 SWOT Analysis
6.7 Dickinson
6.7.1 Dickinson Company Profiles
6.7.2 Dickinson Product Introduction
6.7.3 Dickinson Advanced Parenteral Drug Delivery Devices Production, Revenue (2016-2021)
6.7.4 SWOT Analysis
6.8 Boston Scientific
6.8.1 Boston Scientific Company Profiles
6.8.2 Boston Scientific Product Introduction
6.8.3 Boston Scientific Advanced Parenteral Drug Delivery Devices Production, Revenue (2016-2021)
6.8.4 SWOT Analysis
6.9 Bristol-Myers Squibb
6.9.1 Bristol-Myers Squibb Company Profiles
6.9.2 Bristol-Myers Squibb Product Introduction
6.9.3 Bristol-Myers Squibb Advanced Parenteral Drug Delivery Devices Production, Revenue (2016-2021)
6.9.4 SWOT Analysis6.10 GlaxoSmithKline
6.10.1 GlaxoSmithKline Company Profiles
6.10.2 GlaxoSmithKline Product Introduction
6.10.3 GlaxoSmithKline Advanced Parenteral Drug Delivery Devices Production, Revenue (2016-2021)
6.10.4 SWOT Analysis
6.11 Novartis
6.12 Becton
6.13 AptarGroup
7 Conclusion
-
The (Post pandemic Era) Global Advanced Parenteral Drug Delivery Devices Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
New players are entering the (Post pandemic Era) Global Advanced Parenteral Drug Delivery Devices Market, while established companies are changing their business models and strategies. This pattern is likely to continue for the foreseeable future.
Depending upon the type of applications, the (Post pandemic Era) Global Advanced Parenteral Drug Delivery Devices Market has been segmented into
In recent years, the (Post pandemic Era) Global Advanced Parenteral Drug Delivery Devices Market has grown at an incredible rate. From 2024 to 2029, the market is expected to grow at a CAGR of yy%.
The influx of capital into the (Post pandemic Era) Global Advanced Parenteral Drug Delivery Devices Market, as well as the deployment of technologies designed to increase efficiency and yield high volume, are paving the way for promising market opportunities.
The majority of data for the (Post pandemic Era) Global Advanced Parenteral Drug Delivery Devices Industry is gathered through primary sources, which include interviews and surveys with industry experts from the core and related industries involved in the supply chain. Secondary sources, such as SEC filings, annual reports, whitepapers, and press releases, are also used.
